HGS inks antibody pact with 4-Antibody AG

Switzerland's 4-Antibody AG has forged a new antibody discovery pact, this time with Human Genome Sciences on two undisclosed targets. No numbers were given for the collaboration, which follows on a similar pact that 4-Antibody struck with Boehringer in early 2010. "We're delighted to announce our second collaboration with an established pharmaceutical partner," says CEO Robert Burns. "Collaborations serve an important role in validating our Retrocyte Display technology platform and we're delighted that HGS wanted to enter into this multi-target collaboration with us. This adds an additional momentum to our other ongoing partnering activities." Release

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.